Aminoglycan biosynthetic process

pathway activity — cross-omics
GO:0006023Cross-omicsPROTEIN-MS → RNACellPairwise association · TCGA cohorts

Across TCGA cell cohorts, RNA activity of the Aminoglycan biosynthetic process pathway is significantly associated with the RNA expression of multiple genes, with the BLOOD_Myeloma cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are NEDD9, CRACD, and PTGES, each associated with the pathway in up to 4 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Aminoglycan biosynthetic process activity versus NEDD9 in BLOOD_Myeloma (Pearson r = -0.87).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
BLOOD_MyelomaNEDD9 →-2.753-0.268<.001<.00134
SKINCRACD →+1.167+0.211.004.00234
LARGE_INTESTINEPTGES →-2.486-0.530.002.00934
SKINKRT80 →-2.426-0.255.004.00334
LUNG_NSCLC_LUADUGDH →+1.716+0.352<.001<.00134
CNSADPRH →-1.328-0.305.002.00134
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0006023 vs NEDD9 — BLOOD_Myeloma

Per-sample scatter of Aminoglycan biosynthetic process activity vs NEDD9 in BLOOD_Myeloma.

Explore this scatter interactively →

Exploration